Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 29, 2025
Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8<sup>+</sup> T cell activation in patients with advanced colorectal cancer
Bin Li, Xudong Zhu, Jingyu Ge, et al.
Journal of Hematology & Oncology
|
February 14, 2026
IL-5 CAR-T cell therapy induces effective remission in hypereosinophilic disorders
Youqian Wu, Ruiqi Zhang, Beibei Sun, et al.
Science Translational Medicine
|
March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Nature Communications
|
November 25, 2025
Sonication-induced J-aggregation in nonhalogenated solvents boosts exciton delocalization for high-efficiency organic solar cells
Mingxu Zhou, Xinyue Xu, Dongrui Wang, et al.
Cancer Discovery
|
April 10, 2021
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity
Darya Alizadeh, Robyn A Wong, Sharareh Gholamin, et al.
Nature
|
August 31, 2022
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
Jiqin Zhang, Yongxian Hu, Jiaxuan Yang, et al.
Neuro-Oncology
|
September 12, 2014
VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells
Yuanyuan Chen, Delong Meng, Huibo Wang, et al.
Nature Medicine
|
September 24, 2025
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
Jingjing Feng, Dawei Huo, Ruimin Hong, et al.
Cancer Discovery
|
December 17, 2020
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang, Briana C Prager, Ryan C Gimple, et al.
Cell Reports. Medicine
|
August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety
Michael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 29, 2025
Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8<sup>+</sup> T cell activation in patients with advanced colorectal cancer
Bin Li, Xudong Zhu, Jingyu Ge, et al.
Journal of Hematology & Oncology
|
February 14, 2026
IL-5 CAR-T cell therapy induces effective remission in hypereosinophilic disorders
Youqian Wu, Ruiqi Zhang, Beibei Sun, et al.
Science Translational Medicine
|
March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Nature Communications
|
November 25, 2025
Sonication-induced J-aggregation in nonhalogenated solvents boosts exciton delocalization for high-efficiency organic solar cells
Mingxu Zhou, Xinyue Xu, Dongrui Wang, et al.
Cancer Discovery
|
April 10, 2021
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity
Darya Alizadeh, Robyn A Wong, Sharareh Gholamin, et al.
Nature
|
August 31, 2022
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
Jiqin Zhang, Yongxian Hu, Jiaxuan Yang, et al.
Neuro-Oncology
|
September 12, 2014
VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells
Yuanyuan Chen, Delong Meng, Huibo Wang, et al.
Nature Medicine
|
September 24, 2025
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
Jingjing Feng, Dawei Huo, Ruimin Hong, et al.
Cancer Discovery
|
December 17, 2020
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang, Briana C Prager, Ryan C Gimple, et al.
Cell Reports. Medicine
|
August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety
Michael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Page
of 9